These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 36066271)

  • 61. Assessment of coronary microvascular dysfunction in hypertrophic cardiomyopathy: first-pass myocardial perfusion cardiovascular magnetic resonance imaging at 1.5 T.
    Huang L; Han R; Ai T; Sun Z; Bai Y; Cao Z; Morelli JN; Xia L
    Clin Radiol; 2013 Jul; 68(7):676-82. PubMed ID: 23566329
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Coronary microvascular disease and clinical prognosis in deferred lesions: The index of microcirculatory resistance.
    Chung JH; Lee KE; Park JW; Shin ES
    Clin Hemorheol Microcirc; 2019; 71(2):137-140. PubMed ID: 30584125
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Correlation of left ventricular dyssynchrony on gated myocardial perfusion SPECT analysis with extent of late gadolinium enhancement on cardiac magnetic resonance imaging in hypertrophic cardiomyopathy.
    Yuki H; Utsunomiya D; Shiraishi S; Takashio S; Sakamoto F; Tsuda N; Oda S; Kidoh M; Nakaura T; Tsujita K; Yamashita Y
    Heart Vessels; 2018 Jun; 33(6):623-629. PubMed ID: 29230571
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Young patients with hypertrophic cardiomyopathy, but not subjects at risk, show decreased myocardial perfusion reserve quantified with CMR.
    Gyllenhammar T; Fernlund E; Jablonowski R; Jögi J; Engblom H; Liuba P; Arheden H; Carlsson M
    Eur Heart J Cardiovasc Imaging; 2014 Dec; 15(12):1350-7. PubMed ID: 25139907
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Native T1 time and extracellular volume fraction in differentiation of normal myocardium from non-ischemic dilated and hypertrophic cardiomyopathy myocardium: A systematic review and meta-analysis.
    Minegishi S; Kato S; Takase-Minegishi K; Horita N; Azushima K; Wakui H; Ishigami T; Kosuge M; Kimura K; Tamura K
    Int J Cardiol Heart Vasc; 2019 Dec; 25():100422. PubMed ID: 31517037
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Late gadolinium enhancement location assessed by magnetic resonance and arrhythmogenic risk in hypertrophic cardiomyopathy.
    Barbosa AR; Almeida J; Guerreiro C; Teixeira P; Ladeiras Lopes R; Dias Ferreira N; Sousa O; Braga P
    Rev Port Cardiol (Engl Ed); 2020 Nov; 39(11):615-621. PubMed ID: 33168362
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Microvascular Dysfunction in Hypertrophic Cardiomyopathy.
    Pelliccia F; Cecchi F; Olivotto I; Camici PG
    J Clin Med; 2022 Nov; 11(21):. PubMed ID: 36362787
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Invasive assessment of the coronary microcirculation using the index of microcirculatory resistance: description and validation of an animal model.
    Fiarresga A; Selas M; Oliveira E; Cavaco-Gonçalves S; Cacela D; Carrapiço B; Cardim N; Cruz Ferreira R
    Rev Port Cardiol; 2014 Apr; 33(4):207-12. PubMed ID: 24793616
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Quantitative Flow Ratio-Derived Index of Microcirculatory Resistance as a Novel Tool to Identify Microcirculatory Function in Patients with Ischemia and No Obstructive Coronary Artery Disease.
    Gao B; Wu G; Xie J; Ruan J; Xu P; Qian Y; Gu J; Li W; Jin X; Tong G; Huang J
    Cardiology; 2024; 149(1):14-22. PubMed ID: 37839404
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Coronary microvascular dysfunction: prevalence and aetiology in patients with suspected myocardial ischaemia.
    Kong H; Cao J; Tian J; Yong J; An J; Zhang L; Song X; He Y
    Clin Radiol; 2024 May; 79(5):386-392. PubMed ID: 38433042
    [TBL] [Abstract][Full Text] [Related]  

  • 71. MRI T1 Mapping in Hypertrophic Cardiomyopathy: Evaluation in Patients Without Late Gadolinium Enhancement and Hemodynamic Obstruction.
    Xu J; Zhuang B; Sirajuddin A; Li S; Huang J; Yin G; Song L; Jiang Y; Zhao S; Lu M
    Radiology; 2020 Feb; 294(2):275-286. PubMed ID: 31769741
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Relationship of delayed enhancement by magnetic resonance to myocardial perfusion by positron emission tomography in hypertrophic cardiomyopathy.
    Bravo PE; Zimmerman SL; Luo HC; Pozios I; Rajaram M; Pinheiro A; Steenbergen C; Kamel IR; Wahl RL; Bluemke DA; Bengel FM; Abraham MR; Abraham TP
    Circ Cardiovasc Imaging; 2013 Mar; 6(2):210-7. PubMed ID: 23418294
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Mitral annular plane systolic excursion is an easy tool for fibrosis detection by late gadolinium enhancement cardiovascular magnetic resonance imaging in patients with hypertrophic cardiomyopathy.
    Doesch C; Sperb A; Sudarski S; Lossnitzer D; Rudic B; Tülümen E; Heggemann F; Schimpf R; Schoenberg SO; Borggrefe M; Papavassiliu T
    Arch Cardiovasc Dis; 2015; 108(6-7):356-66. PubMed ID: 25863428
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Phenotypic expression in hypertrophic cardiomyopathy and late gadolinium enhancement on cardiac magnetic resonance.
    Caetano F; Botelho A; Trigo J; Silva J; Almeida I; Venâncio M; Pais J; Sanches C; Leitão Marques A
    Rev Port Cardiol; 2014 May; 33(5):261-7. PubMed ID: 24909443
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Prognostic value of the index of microcirculatory resistance after percutaneous coronary intervention in patients with non-ST-segment elevation acute coronary syndrome.
    Murai T; Yonetsu T; Kanaji Y; Usui E; Hoshino M; Hada M; Hamaya R; Kanno Y; Lee T; Kakuta T
    Catheter Cardiovasc Interv; 2018 Nov; 92(6):1063-1074. PubMed ID: 29446567
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Effect of microcirculatory dysfunction on coronary hemodynamics: A pilot study based on computational fluid dynamics simulation.
    Geng Y; Liu H; Wang X; Zhang J; Gong Y; Zheng D; Jiang J; Xia L
    Comput Biol Med; 2022 Jul; 146():105583. PubMed ID: 35533454
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Angiography-derived index of microcirculatory resistance (IMR
    Scarsini R; Shanmuganathan M; Kotronias RA; Terentes-Printzios D; Borlotti A; Langrish JP; Lucking AJ; ; Ribichini F; Ferreira VM; Channon KM; Garcia-Garcia HM; Banning AP; De Maria GL
    Int J Cardiovasc Imaging; 2021 Jun; 37(6):1801-1813. PubMed ID: 33950329
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Coronary microvascular dysfunction as assessed by multimodal diagnostic imaging in patients with hypertrophic cardiomyopathy is related to the severity of cardiac dysfunction.
    Tran TV; Djaileb L; Riou L; Lantuejoul LR; Giai J; Barone-Rochette G
    Microcirculation; 2024 Feb; 31(2):e12843. PubMed ID: 38174616
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Concurrently Low Coronary Flow Reserve and Low Index of Microvascular Resistance Are Associated With Elevated Resting Coronary Flow in Patients With Chest Pain and Nonobstructive Coronary Arteries.
    Nardone M; McCarthy M; Ardern CI; Nield LE; Toleva O; Cantor WJ; Miner SES
    Circ Cardiovasc Interv; 2022 Mar; 15(3):e011323. PubMed ID: 35135301
    [TBL] [Abstract][Full Text] [Related]  

  • 80. The index of microcirculatory resistance in the physiologic assessment of the coronary microcirculation.
    Martínez GJ; Yong AS; Fearon WF; Ng MK
    Coron Artery Dis; 2015 Aug; 26 Suppl 1():e15-26. PubMed ID: 26247265
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.